NYSE: CPHI - China Pharma Holdings Inc

الربحية لمدة ستة أشهر: -40.49%
عائد الأرباح: 0.00%

جدول الترويج China Pharma Holdings Inc


عن الشركة China Pharma Holdings Inc

China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.

مزيد من التفاصيل
Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate injection to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Ozagrel Sodium to treat acute thrombotic cerebral infarction and dyskinesia; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide injection to treat edema diseases; and Candesartan for hypertension. In addition, the company provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Andrographolide for sore throat caused by upper respiratory tract infection; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. Further it offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Additionally, the company provides Vitamin B6 injection; Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors; Noni Enzyme, a food supplement; sanitizers; and masks. It offers its products through distributors, its network of sales offices, and sales representatives. The company is based in Haikou, the People's Republic of China.

IPO date 2002-04-17
ISIN US16941T1043
Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.chinapharmaholdings.com
Цена ао 0.2638
تغير السعر يوميا: 0% (1.47)
تغير السعر في الأسبوع: +5.08% (1.399)
تغير السعر شهريا: -49.15% (2.891)
تغير السعر خلال 3 أشهر: -29.33% (2.08)
تغير السعر على مدى ستة أشهر: -40.49% (2.47)
تغير السعر سنويا: +297.19% (0.3701)
تغير السعر على مدى 3 سنوات: +297.3% (0.37)
تغير السعر على مدى 5 سنوات: +245.23% (0.4258)
تغير الأسعار منذ بداية العام: -36.77% (2.325)

الاستهانة

اسم معنى درجة
P/S 0 0
P/BV 0 0
P/E 0 0
EV/EBITDA 0 0
المجموع: 2.5

كفاءة

اسم معنى درجة
ROA, % 0 0
ROE, % 0 0
المجموع: 0

توزيعات الأرباح

اسم معنى درجة
Div yield, % 0 0
DSI 0 0
المجموع: 0.1486

واجب

اسم معنى درجة
Debt/EBITDA 0 10
المجموع: 10

دافع النمو

اسم معنى درجة
الربحية Revenue, % -35.82 0
الربحية Ebitda, % -101.95 0
الربحية EPS, % 42.18 6
المجموع: 1.2

مشرف مسمى وظيفي قسط سنة الميلاد
Ms. Zhilin Li President, CEO, Chairman & Interim CFO 1953 (72 سنة)
Ms. Huang Na C.F.A. BOD Secretary & IR Manager

عنوان: China, Haikou, No. 17 Jinpan Road - مفتوحة في خرائط جوجل, فتح خرائط ياندكس
موقع إلكتروني: https://www.chinapharmaholdings.com